A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Clinical trial NCT05506943 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05506943
- Sponsor
- Compass Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2026-12-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.